15 years of heart-failure trials: what have we learned?
- 1 August 1998
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 352, SI29-SI33
- https://doi.org/10.1016/s0140-6736(98)90016-2
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)American Heart Journal, 1997
- Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart FailureNew England Journal of Medicine, 1996
- Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1992
- Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection FractionsNew England Journal of Medicine, 1992
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group.Circulation, 1991
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986
- Verapamil in acute myocardial infarctionEuropean Heart Journal, 1984
- A placebo-controlled trial of captopril in refractory chronic congestive heart failureJournal of the American College of Cardiology, 1983